Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities

Conjugation or deconjugation of ubiquitin (Ub) or ubiquitin‐like proteins (UBLs) to or from cellular proteins is a multifaceted and universal means of regulating cellular physiology, controlling the lifetime, localization, and activity of many critical proteins. Deconjugation of Ub or UBL from prote...

Full description

Saved in:
Bibliographic Details
Published in:Protein science 2008-06, Vol.17 (6), p.1035-1043
Main Authors: Nicholson, Benjamin, Leach, Craig A., Goldenberg, Seth J., Francis, Dana M., Kodrasov, Matthew P., Tian, Xufan, Shanks, John, Sterner, David E., Bernal, Alejandro, Mattern, Michael R., Wilkinson, Keith D., Butt, Tauseef R.
Format: Article
Language:English
Subjects:
Animals
deISGylase
deNEDDylase
deSUMOylase
deubiquitylase
Endopeptidases - isolation & purification
Endopeptidases - metabolism
Mice
Protease Inhibitors - pharmacology
SARS coronavirus
ubiquitin
Ubiquitin - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conjugation or deconjugation of ubiquitin (Ub) or ubiquitin‐like proteins (UBLs) to or from cellular proteins is a multifaceted and universal means of regulating cellular physiology, controlling the lifetime, localization, and activity of many critical proteins. Deconjugation of Ub or UBL from proteins is performed by a class of proteases called isopeptidases. Herein is described a readily quantifiable novel isopeptidase assay platform consisting of Ub or UBL fused to the reporter enzyme phospholipase A2 (PLA2). Isopeptidase activity releases PLA2, which cleaves its substrate, generating a signal that is linear with deubiquitylase (DUB) concentration and is able to discriminate DUB, deSUMOylase, deNEDDylase, and deISGylase activities. The power and sensitivity of the UBL‐PLA2 assay are demonstrated by its ability to differentiate the contrasting deISGylase and DUB activities of two coronavirus proteases: severe acute respiratory syndrome papain‐like protease (SARS‐CoV PLpro) and NL63 CoV papain‐like protease 2 (PLP2). Furthermore, direct comparisons with the current Ub‐7‐amino‐4‐methylcoumarin (Ub‐AMC) assay demonstrated that the Ub‐PLA2 assay is an effective tool for characterizing modulators of isopeptidase activity. This observation was expanded by profiling the inhibitory activity of the nonselective isopeptidase inhibitor NSC 632839 against DUBs and deSUMOylases. Taken together, these studies illustrate the utility of the reporter‐based approach to measuring isopeptidase activity.
ISSN:0961-8368
1469-896X
DOI:10.1110/ps.083450408